Key facts
- This page summarizes Rick D. Anderson's Form 4 filing for Apollo Endosurgery, Inc..
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 16 Jun 2022, 21:21.
Rick D. Anderson - 14 Jun 2022 Form 4 Insider Report for Apollo Endosurgery, Inc.
- Reporting relationship
- Director, 10%+ Owner
- Issuer ticker
- N/A
- Reported as of
- 14 Jun 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 16 Jun 2022, 21:21:48 UTC
- Prior SEC filing
- 13 Jun 2022
- Next SEC filing
- 23 Jun 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Brian Szymczak - Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Rick D. Anderson filed Form 4 for Apollo Endosurgery, Inc. on 16 Jun 2022.
Change
- Previous filing in this sequence was filed on 13 Jun 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
APEN
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +14,224
- Change %
- +14%
- Price
- $0.000000
- Shares after
- 113,484
- Date
- 14 Jun 2022
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
APEN
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +19,333
- Change %
- Price
- $0.000000
- Shares after
- 19,333
- Date
- 14 Jun 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 19,333
- Exercise price
- $3.95
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Represents the grant of Restricted Stock Units ("RSUs"). Each RSU provides the Reporting Person with a contingent right to receive one share of the Issuer's common stock. The RSUs vest on the one year anniversary of the grant date.